Rejuvenate Biomed

  • Home
  • Our team
  • News
  • Events
  • Contact
  • Home
  • Our team
  • News
  • Events
  • Contact
Home News

News

Clinical strategy reviewed by Clinical Advisory Board

Rejuvenate Biomed organized its first Clinical Advisory Board meeting to evaluate the clinical development plan for RJx-01 as a safe therapeutic to treat sarcopenia.

LEARN MORE

Key research collaboration with Prof. Rafael de Cabo

Rejuvenate Biomed collaborates under a CRADA with Dr. Rafael de Cabo, MD, PhD, Professor at the NIA`s Translational Gerontology Branch.

LEARN MORE

VLAIO funding (Baekeland mandate)

Rejuvenate Biomed supports Sven Bulterijs in his PhD under guidance of Prof. Bart Braeckman at Ghent University. His work will focus on C. elegans research in the context of aging.

LEARN MORE

Strategic partnership with PhaRA Consulting to navigate the regulatory pathways

As a partner, PhaRA Consulting will use their regulatory affairs expertise to support Rejuvenate Biomed’s clinical and commercial objectives.

LEARN MORE

VLAIO funding €1.16 million euro to facilitate research

Rejuvenate Biomed has been awarded a €1,160,000 grant from VLAIO to accelerate drug development for healthy aging.

LEARN MORE
  • 1
  • 2
  • 3
  • 4

Rejuvenate Biomed

Rejuvenate Biomed is a science based healthy aging company developing prescription drugs to promote healthy aging.

LETS TALK

Wetenschapspark 13
3590 Diepenbeek
Belgium

View map

Turnhoutseweg 30
2340 Beerse
Belgium

View map

info@rejuvenatebiomed.com

© Copyright 2017-2021 Rejuvenate Biomed NV. All Right Reserved.
  • Privacy Policy
  • Cookie Policy

This website uses cookies to enhance your browsing experience. More information.